Skip to main content

Table 2 Clinical significance of SNHG3 in diverse cancers

From: LncRNA SNHG3, a potential oncogene in human cancers

Cancer types

Overexpression of SNHG3 and clinical features

Refs.

Breast cancer

ER status, HER-2 status, tumor size, histological grade, lymph node metastasis and advanced TNM stage

[31,32,33]

Osteosarcoma

Tumor size and poor overall survival

[25, 38]

Glioma

Poor overall survival

[24]

Laryngeal cancer

No description

[44, 45]

Gastric cancer

Poor prognosis and lymph node metastasis

[23]

Colorectal cancer

Distant metastasis, advanced TNM stage and poor prognosis

[53, 54]

Renal cell carcinoma

Tumor size, distant metastasis, T stage, pathological TNM stage, histologic grade and poor prognosis

[57]

Hepatocellular carcinoma

Tumor size, histologic grade and poor prognosis

[60,61,62,63]

Lung cancer

Tumor size, TNM stage, lymph node migration and poor prognosis

[66, 67]

Leukemia

Poor prognosis

[70, 71]

Ovarian cancer

Poor prognosis, lymph node metastasis, FIGO stage and drug resistance

[26, 74]

Papillary thyroid carcinoma

Lymph node metastasis, tumor node metastasis stages and poor prognosis

[76, 77]

Prostate cancer

No description

[78]

Bladder cancer

Tumor size, metastasis and poor clinical prognosis

[79]

Oral squamous cell carcinoma

No description

[80]

  1. TNM tumor node metastasis, ER estrogen receptor, HER-2 human epidermal growth factor receptor-2, FIGO international federation of gynecology and obstetrics